Focal Photocoagulation as an Adjunctive Therapy to Reduce the Burden of Intravitreal Injections in Macula Edema Patients, the LyoMAC2 Study.
Lucas SéjournetLaurent KodjikianSandra ElbanyBenoit AllignetEmilie AgardMayeul ChaperonJérémy BillantPhilippe DenisThibaud MathisCarole BurillonCorinne DotPublished in: Pharmaceutics (2023)
Focal laser photocoagulation of CMA seems to be effective and safe for reducing the burden of IVI in patients with ME. Their screening during the follow-up should be considered closely.
Keyphrases
- diabetic retinopathy
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- vascular endothelial growth factor
- risk factors
- stem cells
- patient reported outcomes
- mesenchymal stem cells
- mass spectrometry
- platelet rich plasma
- ultrasound guided
- high speed